<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38633561</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2667-646X</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Infectious diseases &amp; clinical microbiology</Title><ISOAbbreviation>Infect Dis Clin Microbiol</ISOAbbreviation></Journal><ArticleTitle>Dark Side of the COVID-19 Pandemic; <i>'Long COVID'</i>.</ArticleTitle><Pagination><StartPage>205</StartPage><EndPage>211</EndPage><MedlinePgn>205-211</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.36519/idcm.2023.213</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">Besides its morbidity and mortality all over the world, SARS-CoV-2 infection maintains its importance with prolonged symptoms after acute disease. The post-infectious period including a heterogeneous group of symptoms is named <i>'long COVID'</i>. This study aimed to describe persisting symptoms three months after COVID-19 and risk factors associated with <i>'long COVID'</i>.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">This cross-sectional retrospective study included COVID-19 patients diagnosed with SARS-CoV-2 PCR positivity in the first 18 months of the COVID-19 pandemic, between March 2020 and September 2021. We conducted a survey in 2022 to inquire about the participants' symptoms that lasted three months or more after their own COVID-19 period. All patients were employees of one of the biggest national banks in Turkey. Participants answered a total of 31 questions over the phone. The presence of one or more symptoms persisting &#x2265;3 months was defined as <i>'long COVID'</i>. The risk factors associated with <i>'long COVID'</i> were determined.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 1301 patients were included in our study. The median age of patients was 40 (22-57), and 558 (42.9%) were women. 257 (19.8%) patients had <i>'long COVID'</i> symptoms. The most prevalent symptoms were myalgia (14.3%), arthralgia (14.1%), and back pain (13.8%). Female gender ( <i>p</i>=0.000, OR=2.19 [95% CI=1.655-2.904]) and diabetes mellitus ( <i>p</i>=0.016, OR=2.43 [95% CI=1.177-5.017]) were found as independent risk factors for <i>'long COVID'</i> by multivariant logistic regression analysis.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Female gender and diabetes mellitus are risk factors for <i>'long COVID'</i>. Detecting patients with a high risk for developing <i>'long COVID'</i> is crucial for their management during the COVID and post-COVID periods.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Infectious Diseases and Clinical Microbiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sar&#x131;cao&#x11f;lu</LastName><ForeName>Elif Mukime</ForeName><Initials>EM</Initials><Identifier Source="ORCID">0000-0002-7613-2398</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Clinical Microbiology, Ankara University School of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;&#x131;nar</LastName><ForeName>G&#xfc;le</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-7635-8848</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Clinical Microbiology, Ankara University School of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azap</LastName><ForeName>Alpay</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5035-055X</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Clinical Microbiology, Ankara University School of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayar</LastName><ForeName>Mustafa K</ForeName><Initials>MK</Initials><Identifier Source="ORCID">0000-0002-0506-4869</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, Ankara University School of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Togay-I&#x15f;&#x131;kay</LastName><ForeName>Canan</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6256-9487</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Ankara University School of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kutlay</LastName><ForeName>&#x15e;ehim</ForeName><Initials>&#x15e;</Initials><Identifier Source="ORCID">0000-0002-6869-6070</Identifier><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Ankara University School of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x130;bi&#x15f;</LastName><ForeName>Sinan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0005-6028-7669</Identifier><AffiliationInfo><Affiliation>Freelance MD, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Turkey</Country><MedlineTA>Infect Dis Clin Microbiol</MedlineTA><NlmUniqueID>9918680988406676</NlmUniqueID><ISSNLinking>2667-646X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post COVID</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>18</Day><Hour>4</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38633561</ArticleId><ArticleId IdType="pmc">PMC10985822</ArticleId><ArticleId IdType="doi">10.36519/idcm.2023.213</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>P&#xe9;rez-Gonz&#xe1;lez A, Ara&#xfa;jo-Ameijeiras A, Fern&#xe1;ndez-Villar A, Crespo M, Poveda E Cohort COVID-19 of the Galicia Sur Health Research Institute. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci Rep. 2022;12(1):3369. doi: 10.1038/s41598-022-07414-x. Erratum in: Sci Rep. 2022;12(1):13873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07414-x</ArticleId><ArticleId IdType="pmc">PMC8888560</ArticleId><ArticleId IdType="pubmed">35233035</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings G, Monaghan A, Xue F, Mockler D, Romero-Ortu&#xf1;o R. A systematic review of persistent symptoms and residual abnormal functioning following acute COVID-19: Ongoing symptomatic phase vs. post-COVID-19 syndrome. J Clin Med. 2021;10(24):5913. doi: 10.3390/jcm10245913.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245913</ArticleId><ArticleId IdType="pmc">PMC8708187</ArticleId><ArticleId IdType="pubmed">34945213</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders C, Sperling S, Bendstrup E. A new paradigm is needed to explain long COVID. Lancet Respir Med. 2023;11(2):12&#x2013;13. doi: 10.1016/S2213-2600(22)00501-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00501-X</ArticleId><ArticleId IdType="pubmed">36620963</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):102&#x2013;107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9):e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021;53(10):737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A, Putrino D. Why we need a deeper understanding of the pathophysiology of long COVID. Lancet Infect Dis. 2023;23(4):393&#x2013;395. doi: 10.1016/S1473-3099(23)00053-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00053-1</ArticleId><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jim&#xe9;nez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021;82(3):378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudzik M, Babicki M, Kapusta J, Ka&#x142;uzi&#x144;ska-Ko&#x142;at &#x17b;, Ko&#x142;at D, Jankowski P, et al. Long-COVID clinical features and risk factors: A retrospective analysis of patients from the STOP-COVID registry of the PoLoCOV study. Viruses. 2022;14(8):1755. doi: 10.3390/v14081755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081755</ArticleId><ArticleId IdType="pmc">PMC9415629</ArticleId><ArticleId IdType="pubmed">36016376</ArticleId></ArticleIdList></Reference><Reference><Citation>Rando HM, Bennett TD, Byrd JB, Bramante C, Callahan TJ, Chute CG, et al. Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information. medRxiv. 2021 Mar 20; doi: 10.1101/2021.03.20.21253896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.20.21253896</ArticleId></ArticleIdList></Reference><Reference><Citation>Living guidance for clinical management of COVID-19, 2021. Geneva: World Health Organization (WHO)  [January 17, 2023]. 
https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2 </Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2. Erratum in: Nat Rev Microbiol. 2023;21(6):408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke MJ, Del Rio C. Long COVID has exposed medicine's blind-spot. Lancet Infect Dis. 2021;21(8):1062&#x2013;1064. doi: 10.1016/S1473-3099(21)00333-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00333-9</ArticleId><ArticleId IdType="pmc">PMC8213360</ArticleId><ArticleId IdType="pubmed">34153235</ArticleId></ArticleIdList></Reference><Reference><Citation>Song WJ, Hui CKM, Hull JH, Birring SS, McGarvey L, Mazzone SB, et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med. 2021;9(5):533&#x2013;544. doi: 10.1016/S2213-2600(21)00125-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00125-9</ArticleId><ArticleId IdType="pmc">PMC8041436</ArticleId><ArticleId IdType="pubmed">33857435</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648 . doi: 10.1136/bmj.n1648. Erratum in: BMJ. 2021;374:n1944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Moschopoulos CD, Margalit I, Gkrania-Klotsas E, Landi F, Stahl JP, et al. ESCMID rapid guidelines for assessment and management of long COVID. Clin Microbiol Infect. 2022;28(7):955&#x2013;972. doi: 10.1016/j.cmi.2022.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Cares-Marambio K, Montenegro-Jim&#xe9;nez Y, Torres-Castro R, Vera-Uribe R, Torralba Y, Alsina-Restoy X, et al. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Chron Respir Dis. 2021;18 doi: 10.1177/14799731211002240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14799731211002240</ArticleId><ArticleId IdType="pmc">PMC7975482</ArticleId><ArticleId IdType="pubmed">33729021</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A, et al. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899. doi: 10.1016/j.eclinm.2021.100899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Ramirez DC, Normand K, Zhaoyun Y, Torres-Castro R. Long-term impact of COVID-19: A systematic review of the literature and meta-analysis. Biomedicines. 2021;9(8):900. doi: 10.3390/biomedicines9080900.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080900</ArticleId><ArticleId IdType="pmc">PMC8389585</ArticleId><ArticleId IdType="pubmed">34440104</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin-Chowdhury Z, Harris R, Aiano F, Zavala M, Bertran M, Borrow R, et al. Characterising post-COVID syndrome more than 6 months after acute infection in adults; prospective longitudinal cohort study, England. medRxiv. doi: 10.1101/2021.03.18.21253633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.18.21253633</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F, G&#xfc;neri FD, Karde&#x15f; S. Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin Rheumatol. 2022;41(1):289&#x2013;296. doi: 10.1007/s10067-021-05942-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05942-x</ArticleId><ArticleId IdType="pmc">PMC8553494</ArticleId><ArticleId IdType="pubmed">34713356</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Pellicer-Valero OJ, Navarro-Pardo E, Palacios-Ce&#xf1;a D, Florencio LL, Guijarro C, et al. Symptoms experienced at the acute phase of SARS-CoV-2 infection as risk factor of long-term post-COVID symptoms: The LONG-COVID-EXP-CM multicenter study. Int J Infect Dis. 2022;116:241&#x2013;244. doi: 10.1016/j.ijid.2022.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.01.007</ArticleId><ArticleId IdType="pmc">PMC8743274</ArticleId><ArticleId IdType="pubmed">35017102</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Galal I, Hussein AARM, Amin MT, Saad MM, Zayan HEE, Abdelsayed MZ, et al. Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score. Egypt J Bronchol. 2021;15(1):10. doi: 10.1186/s43168-020-00049-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43168-020-00049-4</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>